SCHEMBL4727671

SCHEMBL4727671

CCOC(=O)c1cc(OCCCBr)cc(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.54
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 2/20 0.42
BRD4 O60885 2/20 0.41
BRD2 P25440 2/20 0.41
CREBBP Q92793 2/20 0.41
HTT P42858 1/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2771704 0.88 PLA2G2A (0.65) PLA2G2ACYP2C9CYP2C19CA12CA1
SCHEMBL5561218 0.86 PLA2G2A (0.75) PLA2G2ATP53TSHRPLA2G4B
SCHEMBL3176831 0.85 CYP2C9 (0.58) PLA2G2ACYP2C9CYP2C19CA12CA1
SCHEMBL6881775 0.84 PLA2G2A (0.60) PLA2G2ACYP2C9CYP2C19CA12CA1
SCHEMBL3937116 0.83 L3MBTL1 (0.57) PLA2G2ACYP2C9CYP2C19CA12CA1
SCHEMBL19409459 0.83 PLA2G2A (0.64) PLA2G2AL3MBTL1KMT2AHTTTP53
SCHEMBL2828409 0.83 PLA2G2A (0.47) PLA2G2ACA12CA1CA2CA7
SCHEMBL7234951 0.81 CYP2C19 (0.70) CYP2C9CYP2C19CA12CA1CA2
SCHEMBL3327442 0.81 CYP2C19 (0.70) CYP2C9CYP2C19CA12CA1CA2
SCHEMBL27969844 0.81 TPMT (0.48) CYP2C9CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021745-A2 HEPATITIS C VIRUS ENTRY INHIBITORS ITHERX PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed